Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin NL0000200384
Ticker CLB
Company CORE LABORATORIES
Currency $
Price
Aware Investor Index (AII) 40.5383
Recommendation STRONG BUY
P/E 47.62
ROE 100.00 %
Capitalization 7,664,226,960 $
Dividend Yield 1.23 %
P/S 9.61
AII Position 60
P/E Position 587
ROE Position 16
Capitalization Position 539
Dividend Yield Position 477
Sales 797,520,000 $
10-Year Average Earnings 160,935,200 $
Shares Outstanding 42,908,000
Equity -23,699,000 $
Dividend per Share 2.2 $
Industry Oil and Gas
Country Netherlands
CORE LABORATORIES Investor Relations Web Site http://www.corelab.com/investors/







Sales:

YEAR MONTH AMOUNT
2015 12 797,520,000.00 $
2014 12 1,085,222,000.00 $
2013 12 1,073,508,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 114,847,000.00 $
2014 12 257,485,000.00 $
2013 12 242,811,000.00 $
2012 12 216,071,000.00 $
2011 12 184,684,000.00 $
2010 12 144,917,000.00 $
2009 12 113,604,000.00 $
2008 12 131,166,000.00 $
2007 12 121,105,000.00 $
2006 12 82,662,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 -23,699,000.00 $
2014 12 93,993,000.00 $
2013 12 169,389,000.00 $
2012 12 187,913,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 42,908,000
2014 12 44,600,000
2013 12 45,994,000
2012 12 47,553,000

 












Bloomberg News for CORE LABORATORIES:

Mar 11, 2010
North and South American Stock Rating Changes, New Coverage
-------------------------------------------------------------------------------- Core Laboratories N.V. (CLB US) Howard Weil Inc Analyst Recommendation Action Target Blake Hutchinson...
Apr 3, 2006
BKF, Chiron, Cortex, Libbey, LML Payment: U.S. Equity Movers
been this inexpensive'' in the past decade, the analysts wrote in a note. Core Laboratories NV (CLB US) gained $3.76, or 7.9 percent, to $51.31 and traded as high as $52.74. The oilfield-services...
Jun 9, 2010
Largest NYSE Short Interest Ratios as of May 28
278,894 11.2 SUP SUPERIOR INDS 1,734,905 155,453 11.2 CLB CORE LABS NV 3,462,416 311,926 11.1 FMD FIRST MARBLEHEAD ...
Jan 3, 2011
New York Stock Exchange Short Interest as of Dec. 15
720 177,950 ELP COPEL-ADR PR B 1,321,377 1,416,619 344,494 CLB CORE LABS NV 8,302,880 8,543,708 269,824 CLGX CORELOGIC INC...
Feb 18, 2010
North and South American Stock Rating Changes, New Coverage
-------------------------------------------------------------------------------- Core Laboratories N.V. (CLB US) BofAML Analyst Recommendation Action Target Douglas L Becker buy...
Apr 3, 2006
BKF, Gehl, Incyte, Libbey, Sirna, Zap: U.S. Equity Movers Final
been this inexpensive'' in the past decade, the analysts wrote in a note. Core Laboratories NV (CLB US) gained $3.95, or 8.3 percent, to $51.50. The oilfield-services company said in a statement...
Aug 8, 2006
Private Equity Investors to Buy Aramark
shares at about $4.61 per share, at 0.75 Brocade Communications shares for each McData Cl.A and Cl.B share held. McData lowers its second quarter non-GAAP EPS and revenue guidance. Clear Channel...
Mar 4, 2011
U.S. Stock Options With Biggest Changes in Implied Volatility
200 CDE COEUR D'ALE CDE US 06/18/11 C21 20.3 51.6 13.70 17.1 201 CLB CORE LABS N CLB US 04/16/11 C100 20.1 26.5 5.70 54.0 208 MCD MCDONALDS C MCD US 03/19/11...
Mar 25, 2009
Marcial: Core Labs, a Prime Pick in the Energy Patch
Judging by its name alone, one would think that Core Laboratories (CLB) is a drug company or some other type of health-care outfit. It's not, although it does provide a form of "well care." The...
Oct 25, 2004
Ispat Agrees to Acquire International Steel Group
52 CONSTELLATION BRANDS (STZ) offers to acquire for $53 per Cl.A share, $61.75 per Cl.B share. ELAN CORP ADS ELN 10/18/2004 22 In response...


Google News for CORE LABORATORIES:

Nasdaq - 16 hours ago
Why Is Core Laboratories (CLB) Up 5.3% Since Its Last Earnings ...
A month has gone by since the last earnings report for Core Laboratories N.V. CLB . Shares have added about 5.3% in that time frame. Will the ...
Frisco Fastball
Core Laboratories Remains Highly Overvalued
Core Laboratories (NYSE:CLB) reported Q1 revenue of $170 million and EPS of $0.57. Both were in line with expectations. I had the following ...
BangaloreWeekly
Core Laboratories (CLB) Q1 Earnings Meet Estimates, Up Y/Y
Core Laboratories N.V.CLB reported first-quarter 2018 adjusted earnings of 57 cents per share, in line with the Zacks Consensus Estimate.
Week Herald
Core Laboratories NV (CLB)'s AroonUp Indicator Showing Strong ...
Investors have placed Core Laboratories N.V. (CLB) shares on watch as the Aroon Up indicator has moved above 70, indicating that there is ...
Seeking Alpha - 28 Apr 2018
Core Labs: Stock Price Continues To Confound Its Intrinsic Value
This has prompted me to revisit my valuation of Core Labs (NYSE:CLB). Let me state right from the start: I am a long-only investor. I am a ...
Market Exclusive
Investor Brief: Watching the Signals on Shares of Core Laboratories ...
Watching some technical levels for Core Laboratories N.V. (CLB), we have noticed that the current 20-Day Bollinger Bands signal is reading ...
The Ledger Gazette
Drilling Down Into Analyst's Opinions on Core Laboratories NV ...
Focusing in on shares of Core Laboratories N.V. (NYSE:CLB), we have seen that the average broker rating is currently 2.38. This average ...
StockNewsTimes
Consensus Projections in Focus for Core Laboratories NV (NYSE ...
Tracking some earnings projections, we note that the current quarter EPS consensus estimate for Core Laboratories N.V. (NYSE:CLB) is 0.65.
Nasdaq - 26 Apr 2018
Find Hidden Financial Traces with the Analysis for Core ...
Fundamentally, Core Laboratories N.V. (CLB) currently sits with an EPS of 2.05 and a P/E ratio of 61.57. Daily movements in the market may ...
Seeking Alpha
Risk Factors under Consideration – Core Laboratories NV (NYSE ...
Investors rushed to trade on Core Laboratories NV (NYSE: CLB) Monday, soon after a drastic change of 0.54% in the share price was observed ...


Back